Viking Global Investors’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.9M Hold
3,577,128
0.06% 73
2025
Q4
$29.7M Hold
3,577,128
0.08% 74
2025
Q3
$52.2M Hold
3,577,128
0.14% 70
2025
Q2
$40.2M Hold
3,577,128
0.12% 77
2025
Q1
$20.4M Hold
3,577,128
0.06% 83
2024
Q4
$35.1M Hold
3,577,128
0.11% 78
2024
Q3
$29.2M Hold
3,577,128
0.11% 78
2024
Q2
$47.8M Hold
3,577,128
0.18% 70
2024
Q1
$166M Hold
3,577,128
0.62% 40
2023
Q4
$242M Hold
3,577,128
0.89% 38
2023
Q3
$259M Hold
3,577,128
1.05% 30
2023
Q2
$266M Hold
3,577,128
1.09% 35
2023
Q1
$190M Buy
3,577,128
+2,000,000
+127% +$127M 0.89% 33
2022
Q4
$107M Sell
1,577,128
-968,725
-38% -$89.1M 0.53% 49
2022
Q3
$318M Buy
2,545,853
+1,868,750
+276% +$223M 1.47% 25
2022
Q2
$64.5M Sell
677,103
-599,276
-47% -$73.1M 0.29% 61
2022
Q1
$206M Sell
1,276,379
-7,200,000
-85% -$1.4B 0.83% 35
2021
Q4
$2.82B Hold
8,476,379
8.12% 1
2021
Q3
$3.93B Buy
+8,476,379
New +$4.13B 10.78% 1

Other funds holding DNA